{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:02:21Z","timestamp":1793314941497,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T00:00:00Z","timestamp":1739664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["216596\/Z\/19\/Z"],"award-info":[{"award-number":["216596\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000406","name":"Motor Neurone Disease Association","doi-asserted-by":"publisher","award":["899-792"],"award-info":[{"award-number":["899-792"]}],"id":[{"id":"10.13039\/501100000406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000406","name":"Motor Neurone Disease Association","doi-asserted-by":"publisher","award":["974-797"],"award-info":[{"award-number":["974-797"]}],"id":[{"id":"10.13039\/501100000406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000406","name":"Motor Neurone Disease Association","doi-asserted-by":"publisher","award":["972-797"],"award-info":[{"award-number":["972-797"]}],"id":[{"id":"10.13039\/501100000406","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U54 NS092091"],"award-info":[{"award-number":["U54 NS092091"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009281","name":"Fondation Thierry Latran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012257","name":"Cure for MND Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Spinocerebellar ataxia type 2 (SCA2) and amyotrophic lateral sclerosis (ALS) are both associated with a CAG-repeat expansion in\n                    <jats:italic>ATXN2<\/jats:italic>\n                    and with TDP-43-positive neuronal cytoplasmic inclusions. The two disorders have been viewed as distinct entities, where an intermediate length expansion of 31-33 CAG-repeats is associated with sporadic ALS and a full length expansion of \u226534 CAG-repeats is associated with SCA2. We report the clinical phenotype of\n                    <jats:italic>ATXN2<\/jats:italic>\n                    -positive patients and their relatives, identified in three specialist ALS clinics, which force a reconsideration of this dichotomy. We also report the frequency of\n                    <jats:italic>ATXN2<\/jats:italic>\n                    expansions in two large cohorts of ALS patients and in a population-matched cohort of controls. We report ten cases of\n                    <jats:italic>familial<\/jats:italic>\n                    ALS in which disease is associated with either an intermediate or a full-length\n                    <jats:italic>ATXN2<\/jats:italic>\n                    CAG-repeat expansion. Pedigrees and patients feature additional phenotypes including parkinsonism, dementia and essential tremor (ET). We conclude that CAG-repeat expansions in\n                    <jats:italic>ATXN2<\/jats:italic>\n                    exhibit pleiotropy and are associated with a disease spectrum that includes ALS, SCA2, and parkinsonism; to recognise this complexity we propose the new term \u2018\n                    <jats:italic>ATXN2<\/jats:italic>\n                    -related neurodegeneration\u2019. We also observed sporadic ALS associated with full-length expansions. We conclude that\n                    <jats:italic>ATXN2<\/jats:italic>\n                    CAG-repeat expansions, irrespective of length, should be considered a risk factor for ALS. Interrupted CAG-repeats were associated with an ALS phenotype in our data but we also identified ALS cases with uninterrupted expansions. Our findings have relevance for researchers, patients and families linked to CAG-repeat expansions in\n                    <jats:italic>ATXN2<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1038\/s41431-025-01811-2","type":"journal-article","created":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T05:00:41Z","timestamp":1739682041000},"page":"1106-1112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["An observational study of pleiotropy and penetrance of amyotrophic lateral sclerosis associated with CAG-repeat expansion of ATXN2"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9606-0531","authenticated-orcid":false,"given":"Koen C.","family":"Demaegd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3168-1262","authenticated-orcid":false,"given":"Aoife","family":"Kernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0873-8689","authenticated-orcid":false,"given":"Johnathan","family":"Cooper-Knock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke J. F. A.","family":"van Vugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calum","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5928-2514","authenticated-orcid":false,"given":"Tobias","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gornall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Drury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sali M. K.","family":"Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Dion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8403-1418","authenticated-orcid":false,"given":"Guy A.","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Western","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Mclean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Benatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6559-3965","authenticated-orcid":false,"given":"Leonard H.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4010-2357","authenticated-orcid":false,"given":"Philip","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Willem Dankbaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Hendrikse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Koole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"de Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Hobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5572-9657","authenticated-orcid":false,"given":"Jan H.","family":"Veldink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"van de Warrenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jeroen","family":"Pasterkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5860-1533","authenticated-orcid":false,"given":"Wouter","family":"van Rheenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7468-5917","authenticated-orcid":false,"given":"Janine","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7709-5883","authenticated-orcid":false,"given":"Michael. A.","family":"van Es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,16]]},"reference":[{"key":"1811_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00401-011-0862-7","volume":"122","author":"Y Toyoshima","year":"2011","unstructured":"Toyoshima Y, Tanaka H, Shimohata M, Kimura K, Morita T, Kakita A, et al. Spinocerebellar ataxia type 2 (SCA2) is associated with TDP-43 pathology. Acta Neuropathol. 2011;122:375\u20138.","journal-title":"Acta Neuropathol"},{"key":"1811_CR2","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1001\/jamaneurol.2014.2082","volume":"71","author":"AG Neuenschwander","year":"2014","unstructured":"Neuenschwander AG, Thai KK, Figueroa KP, Pulst SM. Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis. JAMA Neurol. 2014;71:1529\u201334.","journal-title":"JAMA Neurol"},{"key":"1811_CR3","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/brain\/awac167","volume":"145","author":"JD Glass","year":"2022","unstructured":"Glass JD, Dewan R, Ding J, Gibbs JR, Dalgard C, Keagle PJ, et al. ATXN2 intermediate expansions in amyotrophic lateral sclerosis. Brain. 2022;145:2671\u20136.","journal-title":"Brain"},{"key":"1811_CR4","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1212\/WNL.0b013e31821f445b","volume":"76","author":"P Van Damme","year":"2011","unstructured":"Van Damme P, Veldink JH, van Blitterswijk M, Corveleyn A, van Vught PWJ, Thijs V, et al. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology. 2011;76:2066\u201372.","journal-title":"Neurology"},{"key":"1811_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1212\/WNL.55.4.569","volume":"55","author":"M Fernandez","year":"2000","unstructured":"Fernandez M, McClain ME, Martinez RA, Snow K, Lipe H, Ravits J, et al. Late-onset SCA2: 33 CAG repeats are sufficient to cause disease. Neurology. 2000;55:569\u201372.","journal-title":"Neurology"},{"key":"1811_CR6","doi-asserted-by":"publisher","first-page":"178.e1","DOI":"10.1016\/j.neurobiolaging.2016.11.010","volume":"51","author":"W Sproviero","year":"2017","unstructured":"Sproviero W, Shatunov A, Stahl D, Shoai M, van Rheenen W, Jones AR, et al. ATXN2 trinucleotide repeat length correlates with risk of ALS. Neurobiol Aging. 2017;51:178.e1\u2013178.e9.","journal-title":"Neurobiol Aging"},{"key":"1811_CR7","first-page":"1302","volume":"70","author":"S Tazen","year":"2013","unstructured":"Tazen S, Figueroa K, Kwan JY, Goldman J, Hunt A, Sampson J, et al. Amyotrophic lateral sclerosis and spinocerebellar ataxia type 2 in a family with full CAG repeat expansions of ATXN2. JAMA Neurol. 2013;70:1302\u20134.","journal-title":"JAMA Neurol"},{"key":"1811_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00401-014-1277-z","volume":"128","author":"D B\u00e4umer","year":"2014","unstructured":"B\u00e4umer D, East SZ, Tseu B, Zeman A, Hilton D, Talbot K, et al. FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion. Acta Neuropathol. 2014;128:597\u2013604.","journal-title":"Acta Neuropathol"},{"key":"1811_CR9","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41431-022-01146-2","volume":"30","author":"K Salmon","year":"2022","unstructured":"Salmon K, Ross JP, Bertone V, Gobbo M, Anoja N, Karamchandani J, et al. The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis. Eur J Hum Genet. 2022;30:1205\u20137.","journal-title":"Eur J Hum Genet"},{"key":"1811_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/brain\/awr365","volume":"135","author":"J Cooper-Knock","year":"2012","unstructured":"Cooper-Knock J, Hewitt C, Highley JR, Brockington A, Milano A, Man S, et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain. 2012;135:751\u201364.","journal-title":"Brain"},{"key":"1811_CR11","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/s41431-018-0177-4","volume":"26","author":"Project MinE ALS Sequencing Consortium.","year":"2018","unstructured":"Project MinE ALS Sequencing Consortium. Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis. Eur J Hum Genet. 2018;26:1537\u201346.","journal-title":"Eur J Hum Genet"},{"key":"1811_CR12","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1093\/bioinformatics\/btz431","volume":"35","author":"E Dolzhenko","year":"2019","unstructured":"Dolzhenko E, Deshpande V, Schlesinger F, Krusche P, Petrovski R, Chen S, et al. ExpansionHunter: a sequence-graph-based tool to analyze variation in short tandem repeat regions. Bioinformatics. 2019;35:4754\u20136.","journal-title":"Bioinformatics"},{"key":"1811_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01085-z","volume":"14","author":"E Dolzhenko","year":"2022","unstructured":"Dolzhenko E, Weisburd B, Iba\u00f1ez K, Rajan-Babu IS, Anyansi C, Bennett MF, et al. Reviewer: haplotype-resolved visualization of read alignments in and around tandem repeats. Genome Med. 2022;14:84.","journal-title":"Genome Med"},{"key":"1811_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1399-0004.2009.01358.x","volume":"78","author":"LE Almaguer-Mederos","year":"2010","unstructured":"Almaguer-Mederos LE, Falc\u00f3n NS, Almira YR, Zaldivar YG, Almarales DC, G\u00f3ngora EM, et al. Estimation of the age at onset in spinocerebellar ataxia type 2 Cuban patients by survival analysis. Clin Genet. 2010;78:169\u201374.","journal-title":"Clin Genet"},{"key":"1811_CR15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/acn3.437","volume":"4","author":"A Antenora","year":"2017","unstructured":"Antenora A, Rinaldi C, Roca A, Pane C, Lieto M, Sacc\u00e0 F, et al. The multiple faces of spinocerebellar ataxia type 2. Ann Clin Transl Neurol. 2017;4:687\u201395.","journal-title":"Ann Clin Transl Neurol"},{"key":"1811_CR16","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1212\/01.wnl.0000269323.21969.db","volume":"69","author":"P Charles","year":"2007","unstructured":"Charles P, Camuzat A, Benammar N, Sellal F, Dest\u00e9e A, Bonnet AM, et al. Are interrupted SCA2 CAG repeat expansions responsible for Parkinsonism? Neurology. 2007;69:1970\u20135.","journal-title":"Neurology"},{"key":"1811_CR17","doi-asserted-by":"publisher","first-page":"e17951","DOI":"10.1371\/journal.pone.0017951","volume":"6","author":"Z Yu","year":"2011","unstructured":"Yu Z, Zhu Y, Chen-Plotkin AS, Clay-Falcone D, McCluskey L, Elman L, et al. PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats. PLoS ONE. 2011;6:e17951.","journal-title":"PLoS ONE"},{"key":"1811_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/21678421.2020.1853172","volume":"22","author":"H Ghahremani Nezhad","year":"2021","unstructured":"Ghahremani Nezhad H, Franklin JP, Alix JJP, Moll T, Pattrick M, Cooper-Knock J, et al. Simultaneous ALS and SCA2 associated with an intermediate-length ATXN2 CAG-repeat expansion. Amyotroph Lateral Scler Front Degener. 2021;22:579\u201382.","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"1811_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51676-0","volume":"15","author":"R Vieira de S\u00e1","year":"2024","unstructured":"Vieira de S\u00e1 R, Sudria-Lopez E, Ca\u00f1izares Luna M, Harschnitz O, van den Heuvel DMA, Kling S, et al. ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes. Nat Commun. 2024;15:7484.","journal-title":"Nat Commun"},{"key":"1811_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/cge.13978","volume":"100","author":"LS Sena","year":"2021","unstructured":"Sena LS, Dos Santos Pinheiro J, Hasan A, Saraiva-Pereira ML, Jardim LB. Spinocerebellar ataxia type 2 from an evolutionary perspective: Systematic review and meta-analysis. Clin Genet. 2021;100:258\u201367.","journal-title":"Clin Genet"},{"key":"1811_CR21","first-page":"842","volume":"60","author":"DH Geschwind","year":"1997","unstructured":"Geschwind DH, Perlman S, Figueroa CP, Treiman LJ, Pulst SM. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia. Am J Hum Genet. 1997;60:842\u201350.","journal-title":"Am J Hum Genet"},{"key":"1811_CR22","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/mdc3.13699","volume":"10","author":"F Casse","year":"2023","unstructured":"Casse F, Courtin T, Tesson C, Ferrien M, No\u00ebl S, Fauret-Amsellem AL, et al. Detection of ATXN2 expansions in an exome dataset: An underdiagnosed cause of parkinsonism. Mov Disord Clin Pract. 2023;10:664\u20139.","journal-title":"Mov Disord Clin Pract"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01811-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01811-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01811-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T05:46:35Z","timestamp":1757137595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01811-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,16]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1811"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01811-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5419198\/v1","asserted-by":"object"}]},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,16]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the South Sheffield Research Ethics Committee. Also, this study followed study protocols approved by Medical Ethical Committees for each of the participating institutions. Written informed consent was obtained from all participating individuals. All methods were performed in accordance with relevant national and international guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}